Stupp protocol

Changed by Frank Gaillard, 27 Apr 2024
Disclosures - updated 26 Oct 2023: Nothing to disclose

Updates to Article Attributes

Title was changed:
Stupp protocol for glioblastoma
Body was changed:

The Stupp protocol has become the standard of care for the treatment of high-grade astrocytoma and glioblastoma since since its publication in 2005 and has led to significant survival improvements 1. It consists of radiotherapy and concomitant chemotherapy with temozolomide, an alkylating agent.

Protocol

According to the original study, the Stupp protocol comprises:

  • radiotherapy

    • total 60 Gy

    • 2 Gy per daily fraction (Monday to Friday) over 6 weeks

  • temozolomide

    • during radiotherapy: 75 75 mg per square metre of body-surface area per day, 7 days per week

    • post-radiotherapy (adjuvant): 6 6 cycles consisting of 150-200 mg per square metre for 5 days during each 28-day cycle

Prognosis

This therapy resulted in a significant survival improvement at 2 years:

  • 26.5% 2-year-survival with Stupp protocol

  • 10.4% 2 2-year-survival with radiotherapy alone

A substantial minority of patients can demonstrate changes of pseudoprogression on follow-up imaging.

History and etymology

The Stupp protocol is named after Roger Stupp the first author of the 2005 paper, who is a Swiss oncologist from the University of Zürich 1.

  • -<p>The <strong>Stupp protocol</strong> has become the standard of care for the treatment of <a href="/articles/glioblastoma-idh-wildtype">glioblastoma</a> since its publication in 2005 and has led to significant survival improvements <sup>1</sup>. It consists of radiotherapy and concomitant chemotherapy with <a href="/articles/temozolomide">temozolomide</a>, an alkylating agent.</p><h4>Protocol</h4><p>According to the original study, the Stupp protocol comprises: </p><ul>
  • +<p>The <strong>Stupp protocol</strong> has become the standard of care for the treatment of high-grade astrocytoma and <a href="/articles/glioblastoma-idh-wildtype">glioblastoma</a>&nbsp;since its publication in 2005 and has led to significant survival improvements <sup>1</sup>. It consists of radiotherapy and concomitant chemotherapy with <a href="/articles/temozolomide">temozolomide</a>, an alkylating agent.</p><h4>Protocol</h4><p>According to the original study, the Stupp protocol comprises:&nbsp;</p><ul>
  • -<li><p><a href="/articles/temozolomide">​</a>during radiotherapy: 75 mg per square metre of body-surface area per day, 7 days per week</p></li>
  • -<li><p>post-radiotherapy (adjuvant): 6 cycles consisting of 150-200 mg per square metre for 5 days during each 28-day cycle</p></li>
  • +<li><p><a href="/articles/temozolomide">​</a>during radiotherapy:&nbsp;75 mg per square metre of body-surface area per day, 7 days per week</p></li>
  • +<li><p>post-radiotherapy (adjuvant):&nbsp;6 cycles consisting of 150-200 mg per square metre for 5 days during each 28-day cycle</p></li>
  • -</ul><h4>Prognosis</h4><p>This therapy resulted in a significant survival improvement at 2 years: </p><ul>
  • +</ul><h4>Prognosis</h4><p>This therapy resulted in a significant survival improvement at 2 years:&nbsp;</p><ul>
  • -<li><p>10.4% 2-year-survival with radiotherapy alone</p></li>
  • -</ul><p>A substantial minority of patients can demonstrate changes of <a href="/articles/tumour-pseudoprogression-brain-tumors" title="Tumour pseudoprogression (brain tumors)">pseudoprogression</a> on follow-up imaging. </p><h4>History and etymology</h4><p>The Stupp protocol is named after <strong>Roger Stupp</strong> the first author of the 2005 paper, who is a Swiss oncologist from the University of Zürich <sup>1</sup>. </p>
  • +<li><p>10.4%&nbsp;2-year-survival with radiotherapy alone</p></li>
  • +</ul><p>A substantial minority of patients can demonstrate changes of <a href="/articles/tumour-pseudoprogression-brain-tumors" title="Tumour pseudoprogression (brain tumors)">pseudoprogression</a> on follow-up imaging.&nbsp;</p><h4>History and etymology</h4><p>The Stupp protocol is named after <strong>Roger Stupp</strong> the first author of the 2005 paper, who is a Swiss oncologist from the University of Zürich <sup>1</sup>.&nbsp;</p>

Updates to Link Attributes

Title was removed:
Stupp protocol for glioblastoma
Type was removed.
Visible changed from true to false.

Updates to Primarylink Attributes

Title was added:
Stupp protocol
Slug was set to stupp-protocol.
Type was set to PrimaryLink.
Visible was set to true.
Content was set to 42300.
Content Type was set to Article.

ADVERTISEMENT: Supporters see fewer/no ads

Updating… Please wait.

 Unable to process the form. Check for errors and try again.

 Thank you for updating your details.